Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. (Q53875699)
Jump to navigation
Jump to search
scientific article published in December 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. |
scientific article published in December 2004 |
Statements
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. (English)
Vassiliki Bozionellou
Dimitris Mavroudis
Maria Perraki
Savvas Papadopoulos
Stella Apostolaki
Efstathios Stathopoulos
Aliki Stathopoulou
Evi Lianidou
Vassilis Georgoulias
1 December 2004
10
24
8185-8194